• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button Iconopioids

opioids

Purdue Pharma makes new offer to settle lawsuits over Oxycontin opioid crisis, and it includes up to $7 billion cash from the Sacklers
Finance
Purdue Pharma makes new offer to settle lawsuits over Oxycontin opioid crisis, and it includes up to $7 billion cash from the Sacklers
By Geoff Mulvihill and The Associated PressMarch 19, 2025
Mexican flag waving
Politics
How do Mexico, Canada, and China affect fentanyl flowing into the U.S.?
By The Associated Press and Jesse BedaynFebruary 4, 2025
Purdue Pharma and Sackler family to pay $7.4 billion in revised settlement of lawsuits over OxyContin opioid toll
Health
Purdue Pharma and Sackler family to pay $7.4 billion in revised settlement of lawsuits over OxyContin opioid toll
By Geoff Mulvihill and The Associated PressJanuary 24, 2025
Ohio Supreme Court says counties can’t sue pharmacy chains in decision that could overturn a $650 million opioid judgment
Health
Ohio Supreme Court says counties can’t sue pharmacy chains in decision that could overturn a $650 million opioid judgment
By Julie Carr Smyth and The Associated PressDecember 11, 2024
Arkansas is suing pharmacy benefit managers Express Scripts and Optum, accusing them of fueling the state’s opioid crisis
Health
Arkansas is suing pharmacy benefit managers Express Scripts and Optum, accusing them of fueling the state’s opioid crisis
By Andrew DeMillo and The Associated PressJune 25, 2024
Gavin Newsom
Health
California partners with pharma firm on generic Narcan amid opioid crisis
By Adam Beam and The Associated PressApril 29, 2024
OxyContin marketer and opioid maker announce $500m in settlements to avoid trials on their responsibility for crisis
Health
OxyContin marketer and opioid maker announce $500m in settlements to avoid trials on their responsibility for crisis
By Geoff Mulvihill and The Associated PressFebruary 2, 2024
EBay will pay $59m settlement over pill presses sold on the site—the kind used to make counterfeit pills laced with fentanyl
Health
EBay will pay $59m settlement over pill presses sold on the site—the kind used to make counterfeit pills laced with fentanyl
By Lindsay Whitehurst and The Associated PressFebruary 1, 2024
OxyContin-maker Purdue Pharma heads to Supreme Court in case over whether $6bn payoff can shield Sackler owners from future lawsuits
Finance
OxyContin-maker Purdue Pharma heads to Supreme Court in case over whether $6bn payoff can shield Sackler owners from future lawsuits
By Mark Sherman and The Associated PressDecember 4, 2023
White patients are more likely than Black patients to be prescribed opioids for pain in US emergency departments. Here’s why it matters
Health
White patients are more likely than Black patients to be prescribed opioids for pain in US emergency departments. Here’s why it matters
By Trevor Thompson, Sofia Stathi and The ConversationOctober 29, 2023
Rite Aid
Retail
Rite Aid’s years of red ink and opioid losses prompt pharmacy giant to file for bankruptcy
By Tom Murphy, Elaine Kurtenbach and The Associated PressOctober 17, 2023
Evan Frostick and Madison Bernard
Health
The opioid crisis is so bad that prosecutors are starting to charge drug addict parents with their kids’ Fentanyl overdoses
By Olga R. Rodriguez and The Associated PressSeptember 8, 2023
Supreme Court
Leadership
Biden’s DOJ doesn’t think the Sackler family should get released from opioid liability and the Supreme Court agrees—for now
By Mark Sherman and The Associated PressAugust 10, 2023
60% of Americans battling drug or alcohol addictions also have jobs. Here are the professions with the highest rates of substance-use disorder
Features
60% of Americans battling drug or alcohol addictions also have jobs. Here are the professions with the highest rates of substance-use disorder
By Erika FryAugust 4, 2023
Secret limits to stop ‘suspicious’ Xanax and Adderall orders are forcing some legitimate patients to scramble
Health
Secret limits to stop ‘suspicious’ Xanax and Adderall orders are forcing some legitimate patients to scramble
By Ike Swetlitz and BloombergApril 3, 2023
1
  • 1
  • 2
  • 3
  • 4
  • 5
5
Most Popular
Big Tech
As Big Tech showers employees with perks to win the talent war, Nvidia built a nearly $5 trillion company by making people pay for their own lunchplaceholder alt text
By Marco Quiroz-GutierrezJuly 1, 2026
Success
MacKenzie Scott alone accounted for one-third of America's $19.2 billion in megagifts last yearplaceholder alt text
By Sydney LakeJune 25, 2026
Newsletters
The Supreme Court's birthright citizenship ruling hands the U.S. economy a $7.7 trillion winplaceholder alt text
By Diane BradyJuly 1, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.